The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

Drug & Diagnostic Development

CSS

August 06-08, 2012 · The Westin San Francisco Market Street · San Francisco, CA

Toolbar

Alternate Language Options:
  • South Korea
  • China
  • Taiwan
  • LinkedIn
  • News Feeds

Overview

Overview

Transforming Clinical and Disease Biology Insights into Drug and Diagnostic Discoveries

A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:

Conference Topics for 2012:

The Future of Rx/Dx Summit

Antibody-Drug Conjugates, Bispecifics & Empowered Antibodies

Next-Gen Sequencing Applications & Translational Technologies

Clinical Biomarkers & New Frontiers in Cancer

  • Rx/Dx Development, Commercialization & Collaboration Models
  • Future Clinical Diagnostics

»More Information
»Download Brochure
»Register

  • Next-Generation Antibody-Drug Conjugates
  • Empowered Antibodies & Bispecifics

»More Information
»Download Brochure
»Register

  • Clinical & Research Applications of Next-Generation Sequencing
  • Translational Biology & Technology

»More Information
»Download Brochure
»Register

  • Clinically-Relevant Biomarkers
  • New Frontiers in Cancer: Novel Clinical Paradigms

»More Information
»Download Brochure
»Register

As an attendee, you can mix-and-match session from all 4 co-located summits

PDF

View the Event-at-a-Glance (PDF) for all 4 co-located Summits.

Gain Scientific and Strategic Insights from these Thought-Leading Speakers:

Joji Nakayama Victor Velculescu, M.D., Ph.D. Richard K. Wilson, Ph.D. Elizabeth Mansfield, Ph.D. Ron A. Andrews Michael J. Pellini, M.D. Garry P. Nolan, Ph.D.

Joji Nakayama, Daiichi-Sankyo, Japan

Victor Velculescu, M.D., Ph.D., Ludwig Center at John Hopkins

Richard K. Wilson, Ph.D., Washington University

Elizabeth S. Mansfield, Ph.D., CDER, US FDA

Ron Andrews, Life Technologies

Michael Pellini, Foundation Medicine

Garry P. Nolan, Ph.D., Stanford School of Medicine

View the Entire Line-up of Keynote & Featured Speakers

View Free Webinars

Next Generation Sequencing At Genomic Health: Turning the Promise of Genomics into the Practice of Medicine
Joffre Baker, Ph.D., Chief Scientific Officer, Genomic Health, Inc.

A New Vision for the Drug-Diagnostic Value Paradigm: Bringing Personalized Medicine to Market
Paul J. Beresford Ph.D., Vice President, Biodesix

Circulating Tumors Cells as Biomarkers: Opportunities for Noninvasive Tumor Characterization and Patient Stratification in Oncology
Yvon E. Cayre, M.D., Ph.D., Professor of Medicine, Pierre and Marie Curie University and Robert Debré University Hospital, France

Upcoming Live Webinar, Register Today

Tuesday, May 22, 2:00 pm EDT
Noninvasive Sequencing of Fetal DNA
Charles Cantor, Ph.D., Chief Scientific Officer, Sequenom, Inc.

»Register to attend these webinars live, or view them archived.

Next Generation Protein Summit